Frequency of Antibiotic Resistance in Helicobacter pylori Strains Isolated from the Northern Population of Iran

다국어 초록 (Multilingual Abstract)

The purpose of this study was to evaluate the primary resistance rates of recent clinical Helicobacter pylori isolates to the most commonly used antibiotics in Iran. Two hundreds and ten patients presenting with gastric maladies between January and July of 2009 were enrolled in this study. Endoscopy was performed, and biopsy specimens were collected from each patient for subsequent bacterial culture of H. pylori. Single colony isolates from each patient were then used for antimicrobial susceptibility testing. The disk diffusion method was used to determine susceptibility patterns. One hundred and ninety-seven of the patients were H. pylori positive (93.8%). The rates of resistance to tetracycline, amoxicillin, ciprofloxacin, metronidazole, clarithromycin, and furizoladone were 37.1%, 23.9%, 34.5%, 65.5%, 45.2%, and 61.4%, respectively. A significant association between amoxicillin resistance and disease state (P<0.05) was identified. Furthermore, some double, triple, quadruple, and quintuple combinations of antibiotic resistance were found to be associated with disease state. This study evaluated the prevalence of H. pylori resistance to the most commonly prescribed antibiotics used in Iran and showed that resistance rates were generally higher than previously reported. This data adds to the growing body of evidence that suggests there is increasing antibiotic resistance among H. pylori isolates, which likely is responsible for the decreasing efficacy of anti-H. pylori therapy at the local and global level. Hence, there is a need for continued monitoring of resistance patterns, especially at the local level, and for incorporation of that information into treatment regimens for H. pylori infections.

참고문헌 (Reference)

1 Jones, K.R, "Who's winning the war? Molecular mechanisms of antibiotic resistance in Helicobacter pylori" 3 : 190-203, 2008

2 O'Connor, A., "Treatment of Helicobacter pylori infection 2010" 15 (15): 46-52, 2010

3 Gao, W., "The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing" 15 : 460-466, 2010

4 Gisbert, J.P., "Sequential therapy for Helicobacter pylori eradication: A critical review" 44 : 313-325, 2010

5 Riahizadeh, S, "Sequential metronidazole-furazolidone or clarithromycinfurazolidone compared to clarithromycin-based quadruple regimens for the eradication of Helicobacter pylori in peptic ulcer disease: A double-blind randomized controlled trial" 15 : 497-504, 2010

6 Boyanova, L, "Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria" 49 : 415-418, 2000

7 Mohammed Ali M. Marie, "Patterns of Helicobacter pylori Resistance to Metronidazole, Clarithormycin and Amoxicillin in Saudi Arabia" 대한미생물학회 38 (38): 173-178, 2008

8 Osato, M.S., "Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the united states" 161 : 1217-1220, 2001

9 Hulten, K, "Macrolide resistance in Helicobacter pylori: Mechanism and stability in strains from clarithromycin-treated patients" 41 : 2550-2553, 1997

10 Siavoshi, F, "Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline-comparison of three 3-year studies" 13 : 177-187, 2010

11 Agudo, S., "High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in madrid" 48 : 3703-3707, 2010

12 Graham, D.Y, "Helicobacter pylori treatment in the era of increasing antibiotic resistance" 59 : 1143-1153, 2010

13 Megraud, F, "Helicobacter pylori detection and antimicrobial susceptibility testing" 20 : 280-322, 2007

14 Elviss, N.C, "Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000" 54 : 567-574, 2000

15 Mohammadi, M., "Helicobacter pylori antibiotic resistance in Iran" 11 : 6009-6013, 2005

16 Dunn, B.E, "Helicobacter pylori" 10 : 720-741, 1997

17 Megraud,F, "H. pylori antibiotic resistance: Prevalence, importance, and advances in testing" 53 : 1374-1384, 2004

18 Boyanova, L, "Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents" 8 : 59-70, 2010

19 Malekzadeh, R, "Gastric cancer in Iran: Epidemiology and risk factors" 12 : 576-583, 2009

20 Segura, A.M., "Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection" 11 : 529-532, 1997

21 Malekzadeh, R, "Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease" 14 : 299-303, 2000

22 Saberi-Firoozi, M, "Experiences with Helicobacter pylori treatment in Iran" 31 : 181-185, 2006

23 Talebi Bezmin Adabi, A, "Evaluation on antibiotic resistance of Helicobacter pylori isolated from patients admitted to tooba medical center, Sari" 19 : 26-32, 2009

24 Vakil, N, "Eradication therapy for Helicobacter pylori" 133 : 985-1001, 2007

25 Blaser,M.J, "Epidemiology and pathophysiology of Campylobacter pylori infections" 12 (12): S99-106, 1990

26 Block, B., "Endoscopy of the upper GI tract: A training manual" Thieme, Mecical Publishers, Inc 194-, 2004

27 Malfertheiner, P., "Current concepts in the management of Helicobacter pylori infection: The maastricht iii consensus report" 56 : 772-781, 2007

28 Dixon, M.F, "Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, Houston 1994" 20 : 1161-1181, 1994

29 Fakheri, H, "Clarithromycin vs. Furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate" 15 : 411-416, 2001

30 Kohanteb, J., "Antimicrobial susceptibility testing of Helicobacter pylori to selected agents by agar dilution method in shiraz-iran" 25 : 374-377, 2007

31 Farshad, S, "Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, southern Iran" 16 : 5746-5751, 2010

32 Siavoshi, F, "Antimicrobial resistance of Helicobacter pylori isolates from iranian adults and children" 9 : 308-314, 2006

33 Wolle, K, "Antibiotic susceptibility of Helicobacter pylori in Germany: Stable primary resistance from 1995 to 2000" 51 : 705-709, 2000

34 Talebi Bezmin Abadi, A, "Antibiotic resistance of Helicobacter pylori in mazandaran, north of iran" 15 : 505-509, 2010

35 Horiki, N., "Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan" 14 : 86-90, 2009

36 Leodolter, A, "A meta-analysis comparing eradication, healing and relapse rates in patients with helicobacter pylori-associated gastric or duodenal ulcer" 15 : 1949-1958, 2001